Showing results (71-80 of 246) with videos related to

Sort By:
Pageof 25
JCO Precision Oncology|March 5, 2026
Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate CancerYu-Wei Chen, Joanne Xiu, Kelsey Anne Poorman, et al.
Prostate Cancer and Prostatic Diseases|February 12, 2024
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumabAndrew B Nixon, Yingmiao Liu, Qian Yang, et al.
Cancer|April 24, 2019
Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177 Lu-J591) for metastatic castration-resistant prostate cancerScott T Tagawa, Shankar Vallabhajosula, Paul J Christos, et al.
The Oncologist|October 7, 2025
Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancerRana R McKay, Shayan S Nazari, Andrew Elliott, et al.
Cancer Research|February 27, 2021
Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate CancerKenji Unno, Zachary R Chalmers, Sahithi Pamarthy, et al.
The Journal of Clinical Investigation|June 22, 2023
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growthGalina Gritsina, Ka-Wing Fong, Xiaodong Lu, et al.
Scientific Reports|October 20, 2018
Plasma androgen receptor and serum chromogranin A in advanced prostate cancerVincenza Conteduca, Emanuela Scarpi, Samanta Salvi, et al.
Human Pathology|August 17, 2014
Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplificationKyung Park, Zhengming Chen, Theresa Y MacDonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO GuidelineEvan Y Yu, R Bryan Rumble, Neeraj Agarwal, et al.
Oncotarget|July 11, 2019
Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activitiesStéphane Terry, Ihsan Y El-Sayed, Damien Destouches, et al.
Pageof 25